BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 37569709)

  • 1. Cholesterol-Depletion-Induced Membrane Repair Carries a Raft Conformer of P-Glycoprotein to the Cell Surface, Indicating Enhanced Cholesterol Trafficking in MDR Cells, Which Makes Them Resistant to Cholesterol Modifications.
    Gutay-Tóth Z; Gellen G; Doan M; Eliason JF; Vincze J; Szente L; Fenyvesi F; Goda K; Vecsernyés M; Szabó G; Bacso Z
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein.
    Bacso Z; Nagy H; Goda K; Bene L; Fenyvesi F; Matkó J; Szabó G
    Cytometry A; 2004 Oct; 61(2):105-16. PubMed ID: 15382145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line.
    Ghetie MA; Marches R; Kufert S; Vitetta ES
    Blood; 2004 Jul; 104(1):178-83. PubMed ID: 15001473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells.
    Dupuis ML; Ascione A; Palmisano L; Vella S; Cianfriglia M
    BMC Pharmacol Toxicol; 2013 Sep; 14():47. PubMed ID: 24053678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-dependent conformational changes of P-glycoprotein are detected by the 15D3 monoclonal antibody.
    Gutay-Tóth Z; Fenyvesi F; Bársony O; Szente L; Goda K; Szabó G; Bacsó Z
    Biochim Biophys Acta; 2016 Mar; 1861(3):188-95. PubMed ID: 26704667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol.
    Luker GD; Nilsson KR; Covey DF; Piwnica-Worms D
    J Biol Chem; 1999 Mar; 274(11):6979-91. PubMed ID: 10066752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
    Noack A; Noack S; Hoffmann A; Maalouf K; Buettner M; Couraud PO; Romero IA; Weksler B; Alms D; Römermann K; Naim HY; Löscher W
    PLoS One; 2014; 9(2):e88154. PubMed ID: 24505408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function.
    Butchbach ME; Tian G; Guo H; Lin CL
    J Biol Chem; 2004 Aug; 279(33):34388-96. PubMed ID: 15187084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?).
    Orlowski S; Martin S; Escargueil A
    Cell Mol Life Sci; 2006 May; 63(9):1038-59. PubMed ID: 16721513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells.
    Kamau SW; Krämer SD; Günthert M; Wunderli-Allenspach H
    In Vitro Cell Dev Biol Anim; 2005; 41(7):207-16. PubMed ID: 16223335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular interaction of a copper chelate with human P-glycoprotein.
    Ghosh RD; Chakraborty P; Banerjee K; Adhikary A; Sarkar A; Chatterjee M; Das T; Choudhuri SK
    Mol Cell Biochem; 2012 May; 364(1-2):309-20. PubMed ID: 22258826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.
    Fung KL; Pan J; Ohnuma S; Lund PE; Pixley JN; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
    Cancer Res; 2014 Jan; 74(2):598-608. PubMed ID: 24305879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function of the ATP-binding cassette (ABC) transporter ABCB1 is not susceptible to actin disruption.
    Meszaros P; Hummel I; Klappe K; Draghiciu O; Hoekstra D; Kok JW
    Biochim Biophys Acta; 2013 Feb; 1828(2):340-51. PubMed ID: 23085402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts.
    Ghetie MA; Crank M; Kufert S; Pop I; Vitetta E
    J Immunother; 2006; 29(5):536-44. PubMed ID: 16971809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
    Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
    Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis.
    Le Goff W; Settle M; Greene DJ; Morton RE; Smith JD
    J Lipid Res; 2006 Jan; 47(1):51-8. PubMed ID: 16215259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
    De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
    J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
    Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase.
    Zhou Y; Gottesman MM; Pastan I
    Mol Cell Biol; 1999 Feb; 19(2):1450-9. PubMed ID: 9891078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol.
    Foster JD; Adkins SD; Lever JR; Vaughan RA
    J Neurochem; 2008 Jun; 105(5):1683-99. PubMed ID: 18248623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.